Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songhang Wu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cellular and Molecular Gastroenterology and Hepatology|October 25, 2023
Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT SignalingYuchen Ye, Ya Fu, Caorui Lin, et al.
Journal of Clinical Microbiology|June 14, 2019
Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation SequencingYa Fu, Yongbin Zeng, Tianbin Chen, et al.
Emerging Microbes & Infections|September 14, 2022
Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinomaYa Fu, Fengling Fang, Hongyan Guo, et al.
Gut|October 3, 2023
Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infectionCaorui Lin, Linjie Luo, Zhen Xun, et al.
Cellular & Molecular Immunology|January 12, 2021
Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8<sup>+</sup> T and NK cell functionZhen Xun, Jinpiao Lin, Qingqing Yu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cellular and Molecular Gastroenterology and Hepatology|October 25, 2023
Oncostatin M Induces IFITM1 Expression to Inhibit Hepatitis B Virus Replication Via JAK-STAT SignalingYuchen Ye, Ya Fu, Caorui Lin, et al.
Journal of Clinical Microbiology|June 14, 2019
Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation SequencingYa Fu, Yongbin Zeng, Tianbin Chen, et al.
Emerging Microbes & Infections|September 14, 2022
Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinomaYa Fu, Fengling Fang, Hongyan Guo, et al.
Gut|October 3, 2023
Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infectionCaorui Lin, Linjie Luo, Zhen Xun, et al.
Cellular & Molecular Immunology|January 12, 2021
Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8<sup>+</sup> T and NK cell functionZhen Xun, Jinpiao Lin, Qingqing Yu, et al.
Pageof 2